Novozymes Capex To Revenue from 2010 to 2024

Pink Sheets . USA . 
Stock . Novozymes AS B
NVZMF Stock  USD 58.80  0.24  0.41%   
Check Novozymes A/S financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novozymes A/S's main balance sheet or income statement drivers, such as , as well as many indicators such as . Novozymes financial statements analysis is a perfect complement when working with Novozymes A/S Valuation or Volatility modules.
  
This module can also supplement various Novozymes A/S Technical models . Check out the analysis of Novozymes A/S Correlation against competitors.

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors

Other Information on Investing in Novozymes Pink Sheet

Novozymes A/S financial ratios help investors to determine whether Novozymes Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novozymes with respect to the benefits of owning Novozymes A/S security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY